Erik Magnus Ohman, MBBS

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 8678A Hafs Bldg, Durham, NC 27710
Phone (919) 681-2069
Email address ohman001@mc.duke.edu

Dr. Ohman, Professor of Medicine, received medical degrees from the Royal College of Surgeons in Ireland and the National University of Ireland (1984, Fellowship 1984-1987), and completed his training in cardiology at Duke University (1987-1991), where he has remained on faculty. In 2001, he became Chief of Cardiology at the University of North Carolina at Chapel Hill, where he founded the UNC Heart Center and became its first director. In 2005 he returned to Duke to pursue his interest in advanced coronary disease as the Director of the Program for Advanced Coronary Disease. Since that time, he has been appointed to Associate Director of the Duke Heart Center, the Kent and Siri Rawson Director for the Program for Advanced Coronary Disease, and most recently, Vice-Chair of Development and Innovation in the Department of Medicine.

Dr. Ohman’s clinical and research interests include interventional cardiology and high-risk supported PCI, and treatment of patients with advanced/complex coronary disease. He has researched how to improve patient care through the use of guidelines-based therapies and adherence, and examining global cardiovascular risk and health. He has been a participant on numerous guidelines writing committees, served on the ACC/AHA oversight committee for guidelines development, and has served on the steering committees for trials on ST-elevation myocardial infarction and non-ST-elevation ACS. He is a consultant to the National Institutes of Health, and a consultant for the FDA Advisory Panel for Cardiovascular Devices. 

Dr. Ohman has published over 600 peer-reviewed papers and three books in cardiovascular medicine. He holds three U.S. patents in reperfusion therapy. He is an associate editor for the American Heart Journal and serves on the editorial boards of the Journal of the American College of Cardiology and the American Journal of Cardiology.  He is a Fellow of the Royal College of Physicians in Ireland, the Royal Society of Medicine (U.K.), the European Society of Cardiology, the Society of Cardiac Angiography and Interventions, and the American College of Cardiology. 

Education and Training

  • M.B.B.S., Royal College of Surgeons (Ireland), 1981

Publications

Davidson, C. J., K. H. Sheikh, K. B. Kisslo, H. R. Phillips, R. H. Peter, V. S. Behar, Y. H. Kong, M. Krucoff, E. M. Ohman, and J. E. Tcheng. “Intracoronary ultrasound evaluation of interventional technologies..” Am J Cardiol 68, no. 13 (November 15, 1991): 1305–9.

PMID
1951117
Scholars@Duke

Hellstrom, H. R. “Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction..” Circulation 84, no. 3 (September 1991): 1454–55.

PMID
1884472
Scholars@Duke

Christenson, R. H., E. M. Ohman, R. T. Vollmer, P. Clemmensen, P. Grande, and G. S. Wagner. “Serum release of the creatine kinase tissue-specific isoforms MM3 and MB2 is simultaneous during myocardial reperfusion..” Clin Chim Acta 200, no. 1 (August 15, 1991): 23–33.

PMID
1934508
Scholars@Duke

Califf, R. M., D. F. Fortin, D. J. Frid, W. R. Harlan, E. M. Ohman, J. R. Bengtson, C. L. Nelson, J. E. Tcheng, D. B. Mark, and R. S. Stack. “Restenosis after coronary angioplasty: an overview..” J Am Coll Cardiol 17, no. 6 Suppl B (May 1991): 2B-13B.

PMID
2016478
Scholars@Duke

Ohman, E. M., R. M. Califf, B. S. George, P. J. Quigley, D. J. Kereiakes, L. Harrelson-Woodlief, R. J. Candela, C. Flanagan, R. S. Stack, and E. J. Topol. “The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group..” Am Heart J 121, no. 3 Pt 1 (March 1991): 895–901.

PMID
1900381
Scholars@Duke

Ohman, E. M., R. M. Califf, E. J. Topol, R. S. Stack, and B. S. George. “Intra-aortic balloon pumping: Benefits after thrombolytic therapy.” Cardiology Board Review 8, no. 11 (January 1, 1991): 41–56.

Scholars@Duke

Ohman, E. M., R. M. Califf, B. S. George, P. J. Quigley, D. J. Kereiakes, L. Harrelson-Woodlief, R. J. Candela, C. Flanagan, R. S. Stack, and E. J. Topol. “The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction.” American Heart Journal 121, no. 3 PART 1 (January 1, 1991): 895–901. https://doi.org/10.1016/0002-8703(91)90205-V.

Full Text

Clemmensen, P., E. M. Ohman, D. C. Sevilla, S. Peck, N. B. Wagner, P. S. Quigley, P. Grande, K. L. Lee, and G. S. Wagner. “Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction..” Am J Cardiol 66, no. 20 (December 15, 1990): 1407–11.

PMID
2123601
Scholars@Duke

Gurbel, P. A., C. J. Davidson, E. M. Ohman, J. E. Smith, and R. S. Stack. “Selective infusion of thrombolytic therapy in the acute myocardial infarct-related coronary artery as an alternative to rescue percutaneous transluminal coronary angioplasty..” Am J Cardiol 66, no. 12 (October 15, 1990): 1021–23.

PMID
2121014
Scholars@Duke

Ohman, E. M., K. N. Sigmon, and R. M. Califf. “Is diagnostic certainty essential for the use of thrombolytic therapy during myocardial infarction in the 1990s?.” Circulation 82, no. 3 (September 1990): 1073–75.

PMID
2393996
Scholars@Duke

Pages